Stay updated on NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.

Latest updates to the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.6.6 was added, replacing Revision: v3.6.5. This indicates a small software update to the page’s version information.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision label has been updated to v3.6.5, replacing the previous v3.6.4 and indicating a new site version.SummaryDifference0.0%

- Check42 days agoChange DetectedFooter revision label updated from v3.6.3 to v3.6.4, indicating a small platform update to the history page.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page history shows Revision: v3.6.3 replacing Revision: v3.6.2, indicating a minor site version update rather than changes to trial information.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page’s revision label updates from Revision: v3.6.0 to Revision: v3.6.2, signaling a newer site release without changing the study history content.SummaryDifference0.0%

- Check85 days agoChange DetectedRecruitment status updated to 'No longer looking for participants', indicating no active enrollment. The version history shows a new Revision: v3.6.0, replacing the prior Revision: v3.5.5.SummaryDifference0.2%

Stay in the know with updates to NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NKTR-214 Combo vs Nivolumab in Melanoma Clinical Trial page.